Shenzhen Salubris Pharmaceutical Co.
Shenzhen, China · $260.0M raised
- Headquarters
- Shenzhen
- Employees
- 1001–5000
- Business Model
- B2B
- Website
- salubrisbio.com
- Total Funding
- $260.0M
- Last Round
- $260.0M Private EquitySep 2020
- Rounds
- 1
About
Innovation-driven pharmaceutical company based in Shenzhen, China, focused on developing novel therapeutics including antibody and protein-based treatments.
Summary
Shenzhen Salubris Pharmaceutical Co. is a Biotech company based in Shenzhen, China. It has raised $260.0M in total across 1 round, most recently a $260.0M Private Equity round in Sep 2020. Investors include Carlyle.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2020
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...